Stay updated on Losartan and Nivolumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page
- Check4 days agoChange DetectedNo changes were recorded for this page. The study overview, design, and eligibility criteria remain as published.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe study record revision was updated from v3.6.2 to v3.6.3, indicating a minor update to the page version. The change reflects an incremental update to the publicly posted record rather than substantive content changes.SummaryDifference0.0%

- Check25 days agoChange DetectedSite revision updated from v3.6.0 to v3.6.2, reflecting a backend platform update on the study page. No study details or navigation are affected.SummaryDifference0.0%

- Check39 days agoChange DetectedDifference0.4%

- Check46 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, signaling a minor update to the page's build or content management system. This update does not modify the study details, eligibility criteria, or results presented on the page.SummaryDifference0.0%

- Check68 days agoChange DetectedA revision label was updated from v3.5.3 to v3.5.4. This indicates a minor update to the page's versioning or metadata rather than substantive content changes.SummaryDifference0.0%

Stay in the know with updates to Losartan and Nivolumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Losartan and Nivolumab in Pancreatic Cancer Clinical Trial page.